Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile

NCT03025672 | Completed DMC

• 1 other identifier: OBS-021
• Study Type: observational
• Target: 10,445
• Locations: 0 countries
• Sites: N/A

Brief Summary

Clostridium difficile is the first cause of nosocomial infectious diarrhea, due to its mode of transmission and its resistance in the environment. Nosocomiality is defined by the apparition of an infection 48 hours after the patient's hospitalization. Clostridium difficile contamination occurs oro-fecally and is transmitted directly through the hand or from the contaminated environment (during care or not). By implementing prevention and optimal treatment, nosocomial infections are preventable. A clostridium difficile infection causes an additional cost of patient care for the hospital. This additional cost is principally due to the increase of the length of the stay. It varies according to patient risk factors,and also according to the reason of the hospitalization and can vary from 300 euros (\~317$) to more than 25.000 euros (26.460$). By determining the increase in the length of the stay and the additional cost due to a clostridium difficile infection in the GHICL (Groupement des Hôpitaux de l'Institut Catholique de Lille), prevention will be valued and measures against those infections should be easier to set up. The main objective of this study is to evaluate the additional cost of an infection by clostridium difficile.

Conditions

Cross Infection; Clostridium Difficile Infection

Outcome Measures

Primary Outcomes (1)

• Difference between patient cost and income for the hospital based on the PMSI rate.

  The difference between the real cost of the patient stay, included the additional costs due to clostridium difficile infection, and the public funding (calculated using the PMSI) for this stay will be computed.

  Day 1

Study Arms (2)

clostridium difficile

Patients that have been infected by clostridium difficile during their stay in hospital

no clostridium difficile

Patients that have not been infected during their stay in hospital.

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients that have stayed in an hospital of the GHICL in 2013 and 2014

You may qualify if:

• Patients that have stayed in an hospital of the GHICL between January 2013 and September 2015.

You may not qualify if:

• none

Sponsors & Collaborators

• Lille Catholic University: lead

MeSH Terms

Conditions

Cross Infection; Clostridium Infections

Condition Hierarchy (Ancestors)

Infections; Iatrogenic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Gram-Positive Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 10, 2017
• First Posted: January 19, 2017
• Study Start: April 1, 2015
• Primary Completion: January 1, 2017
• Study Completion: January 1, 2017
• Last Updated: January 19, 2017

Record last verified: 2017-01

Data Sharing

• IPD Sharing: Will not share